Serum interleukin-10 in ICU patients with severe acute central nervous system injuries

Inflammation Research

Volumn 53, Issue 8, 2004, Pages 338-343

  Dziurdzik, P ^a,b   Krawczyk, L ^a,b   Jalowiecki, P ^a,b   Kondera Anasz, Z ^a,c   Menon, L ^a,b  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b Wojewodzki Szpital S   (Poland)

^c Kat Zaklad Immunologii S   (Poland)

Author keywords

Brain injury; Central nervous system; Intensive care; Interleukin 10

Indexed keywords

CYTOKINE; INTERLEUKIN 10;

ADULT; ARTICLE; BLOOD ANALYSIS; BRAIN HEMORRHAGE; BRAIN INJURY; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFECTION RISK; INJURY SCALE; INTENSIVE CARE UNIT; PROGNOSIS; PROTEIN BLOOD LEVEL; STATISTICAL SIGNIFICANCE;

EID: 4344592117     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00011-004-1265-1     Document Type: Article

References (29)

1. Helling TS, Evans LL, Fowler DL, Hays LV, Kennedy FR. Infectious complications in patients with severe head injury. J Trauma 1988; 28: 1575-7.
2. Meert KL, Long M, Kaplan J, Sarnaik AP. Alterations in immune function following head injury in children. Crit Care Med 1995; 23: 822-8.
3. Lyonns A, Kelly JL, Rodrick ML, Mannick JA, Lederer JA. Major injury induces increased production of interleukin-10 by cells of the immune system with negative impact on resistance to infection. Ann Surg 1997; 226: 450-60.
4. Partrick DA, Moore EE, Moore FA, Biffl WL, Barnett CC. Release of antiinfiammatory mediators after major torso trauma correlates with the development of postinjury multiple organ failure. Am J Surg 1999; 178: 564-9.
5. Sherry RM, Cue JI, Goddard JK, Parramore JB, DiPiro JT. Interleukin-10 is associated with the development of sepsis in trauma patients. J Trauma 1996; 40: 613-6.
6. Neidhardt R, Keel M, Steckholzer U, Safret A, Ungethuem U, Trentz O et al. Relationship of interleukin-10 plasma levels to severity of injury and clinical outcome in injured patients. J Trauma 1997; 42: 863-70.
7. Shimonkevitz R, Bar-Or D, Harris L, Dole K, McLaughlin L, Yukl R. Transient monocyte release of interleukin-10 in response to traumatic brain injury. Shock 1999; 12: 10-6.
8. Spera PA, Ellison JA, Feuerstein GZ, Barone FC. IL-10 reduces rat brain injury following focal stroke. Neurosci Lett 1998; 51: 89-92.
9. Knoblach SM, Faden AI. Interleukin-10 improves outcome and alters proinflammatory cytokine expression after experimental traumatic brain injury. Exp Neurol 1998; 153: 143-51.
10. Endogen, Inc. Human ELISA IL-10 kit manual. 8 Gill Street, Woburn (MA), USA.
11. Csuka E, Morganti-Kossman CM, Lenzlinger PM, Joller H, Trentz O, Kossmann T. IL-10 levels in cerebrospinal fluid and serum of patients with severe traumatic brain injury: relationship to IL-6, TNF-alpha, TGF-beta1 and blood-brain barrier function. J Neuroimmunol 1999; 101: 211-21.
12. Maskin B, Gammaella D, Solari L, Videta W, Barboza MF, Geliz L et al. Early release of the antiinflammatory cytokine IL-10 in traumatic brain injury. Medicina (Buenos Aires) 2001; 61: 573-6.
13. Bell MJ, Kochanek PM, Doughty LA, Carcillo JA, Adelson PD, Clark RS et al. Interleukin-6 and interleukin-10 in cerebrospinal fluid after severe traumatic brain injury in children. J Neurotrauma 1997; 4: 451-7.
14. Bell MJ, Kochanek PM, Doughty LA, Carcillo JA, Adelson PD, Clark RS et al. Comparison of the interleukin-6 and interleukin-10 response in children after severe traumatic brain injury or septic shock. Acta Neurochir Wien 1997; 70 (Suppl.): 96-7.
15. Taniguchi T, Koido Y, Aiboshi J, Yamashita T, Suzaki S, Kurokawa A. Change in the ratio of interleukin-6 to interleukin-10 predicts a poor outcome in patients with systemic inflammatory response syndrome. Crit Care Med 1999; 27: 1262-5.
16. Pelidou SH, Kostulas N, Matusevicius D, Kivisakk P, Kostulas V, Link H. High levels of IL-10 secreting cells are present in blood in cerebrovascular diseases. Eur J Neurol 1999; 6: 437-42.
17. Woiciechowsky C, Asadullah K, Nestler D, Eberhardt B, Platzer C, Schoning B et al. Sympathetic activation triggers systemic interleukin-10 release in immunodepression induced by brain injury. Nat Med. 1998; 4: 808-13.
18. Docke WD, Jacobi C, Eberhardt B, Platzer C, Woiciechowsky C, Felix S et al. Role of IL-10 in monocyte deactivation after injury and stress. Presumed mechanisms. Shock 1997; 8 (Suppl.): 115.
19. Platzer C, Docke W, Volk H, Prosch S. Catecholamines trigger IL-10 release in acute systemic stress reaction by direct stimulation of its promoter/enhancer activity in monocytic cells. J Neuroimmunol 2000; 105: 31-8.
20. Heesen M, Deinsberger W, Dietrich GV, Detsch O, Boldt J, Hempelmann G. Increase of interleukin-6 plasma levels after elective craniotomy: influence of interleukin-10 and catecholamines. Acta Neurochir Wien 1996; 138: 77-80.
21. Hensler T, Sauerland S, Riess P, Hess S, Helling HJ, Andermahr J et al. The effect of additional brain injury on systemic interleukin (IL)-10 and IL-13 levels in trauma patients. Inflamm Res 2000; 49: 524-8.
22. Hensler T, Sauerland S, Bouillon B, Raum M, Rixen D, Helling HJ et al. Association between injury pattern of patients with multiple injuries and circulating levels of soluble tumor necrosis factor receptors, interleukin-6 and interleukin-10, and polymorphonuclear neutrophil elastase. J Trauma 2002; 52: 962-70.
23. Woiciechowsky C, Schoning B, Lanksch WR, Volk HD, Docke WD. Mechanisms of brain-mediated systemic anti-inflammatory syndrome causing immunodepression. J Mol Med 1999; 77: 769-80.
24. Moore KW, O'Garra A, de Waal MR, Vieira P, Mosmann TR. Interleukin-10. Ann Rev Immunol 1993; 11: 165-90.
25. Goldman M, Marchant A. Interleukin-10 production during septic shock. In: Vincent JL, editor. Yearbook of intensive care and emergency medicine. Berlin-Heidelberg: Springer-Verlag, 1996: 105-10.
26. Marchant A, Bruyns C, Vandenabeele P, Ducarme M, Gerard C, Delvaux A et al. Interleukin-10 controls interferon-γ and tumor necrosis factor production during experimental endotoxemia. Eur J Immunol 1994; 24: 1167-71.
27. Gerard C, Bruyns C, Marchant A, Abramowicz D, Vandenabeele P, Delvaux A et al. Interleukin-10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med 1993; 177: 547-50.
28. Howard M, Muchamuel TT, Andrade S, Menon S. Interleukin-10 protects mice from lethal endotoxemia. J Exp Med 1993; 177: 1205-8.
29. Majetschak M, Borgermann J, Waydhas C, Obertacke U, Nast.-Kolb D, Shade FU. Whole blood tumor necrosis factor-alpha production and its relation to systemic concentrations of interleukin-4, interleukin-10, and transforming growth factor-beta1 in multiply injured blunt trauma victims. Crit Care Med 2000; 28: 1847-53.